Goleta-based biotech Serimmune appoints new CEO

You are here: Home > Biotech > Current Article

Goleta-based biotech Serimmune appoints new CEO

By Staff Report / Tuesday, August 6th, 2019 / Comments Off on Goleta-based biotech Serimmune appoints new CEO

Noah Nasser Goleta-based biotechnology and data company Serimmune appointed a new CEO Aug. 6 and added a seat to its board of directors. Noah Nasser, formerly chief commercial officer at San Diego genomic company Human Longevity and DNA screening firm Counsyl, joined the company as CEO. In the role, Nasser will oversee the commercialization of…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.